Athersys (Athersys) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 07, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Athersys EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Biotechnology subindustry, Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.

Athersys (OTCPK:ATHXQ) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Athersys EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Athersys's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Athersys (Athersys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (OTCPK:ATHXQ) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Comparable Companies

Traded in Other Exchanges

N/A

Address

3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634

Website

https://www.athersys.com

Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Executives

Neema Mayhugh	director	3201 CARNEGIE AVE, CLEVELAND OH 44115
Joseph Patrick Nolan	director	100 PARK LANE, LAKE BLUFF IL 60044
Daniel A. Camardo	director, officer: Chief Executive Officer	ATHERSYS, INC., 3201 CARNEGIE AVE, CLEVELAND OH 44115
Maia Hansen	officer: Chief Operating Officer	16430 N. SCOTTSDALE ROAD, SCOTTSDALE AZ 85254
Kasey Rosado	officer: Interim, CFO	485 LEXINGTON AVE 10TH FLOOR, NEW YORK NY 10017
Ismail Kola	director	3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Ivor Macleod	officer: Chief Financial Officer	3201 CARNEGIE AVENUE, CLEVELAND OH 44115-2634
William Jr Lehmann	officer: President	3201 CARNEGIE AVENUE, CLEVELAND OH 44115
John J Harrington	director, officer: Chief Scientific Officer	3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Laura K Campbell	officer: Vice President	3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Katherine Bach Kalin	director	3201 CARNEGIE AVENUE, CLEVELAND OH 44115
Baiju R. Shah	director	ONE INVACARE WAY, ELYRIA OH 44035
Jane Wasman	director	C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Kenneth H Traub	director
Tadahisa Kagimoto	director, 10 percent owner	HEALIOS K.K., WORLD TRADE CENTER BLDG., 15F, 2-4-1 HAMAMATSUCHO, MINATO-KU, TOKYO M0 1056115